AstraZeneca announced that the FDA has approved Tagrisso (osimertinib, formerly AZD 9291) 80 mg once-daily tablets for the treatment of...
As a topical ocular anaesthetic.
The 2017 guidance is based on new evidence about how effective prescribing and delivery of emergency oxygen for patients can improve health and saved lives.
Hyperbaric oxygen therapy (HBOT) has been used as an adjuvant treatment for multiple pathological states, which involves hypoxic conditions.